| Oct 30 |
NovoCure: Q3 Earnings Snapshot
|
| Oct 30 |
Novocure Appoints Christoph Brackmann as Chief Financial Officer
|
| Oct 30 |
NovoCure GAAP EPS of -$0.28 beats by $0.05, revenue of $155.09M beats by $11.14M
|
| Oct 30 |
Novocure Reports Third Quarter 2024 Financial Results
|
| Oct 29 |
NovoCure Q3 2024 Earnings Preview
|
| Oct 17 |
Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment
|
| Oct 17 |
NovoCure scoops FDA approval on wearable for metastatic cancer treatment
|
| Oct 16 |
NovoCure: There Is Still More Upside
|
| Oct 16 |
Novocure wins FDA approval for electric field device in lung cancer
|
| Oct 16 |
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
|
